The global Gene Synthesis Market is witnessing rapid growth as increasing demand for synthetic biology, precision medicine, genetic engineering, and advanced biotechnology research encourages market expansion. Growing applications of synthetic genes across pharmaceuticals, vaccine development, cell therapy, agricultural biotechnology, molecular diagnostics, and industrial biotechnology are further supporting market growth. Advancements in automation, artificial intelligence, high-throughput DNA synthesis, and sequence optimization are creating new opportunities for gene synthesis service providers and technology developers.
According to Fortune Business Insights, the global Gene Synthesis Market was valued at USD 2.81 billion in 2025 and is projected to grow from USD 3.27 billion in 2026 to USD 10.99 billion by 2034, exhibiting a CAGR of 16.36% during 2026–2034.
Gene Synthesis Market Growth Drivers
The growing demand for synthetic biology and precision medicine is a major factor driving market growth. Pharmaceutical companies, biotechnology firms, and academic research organizations increasingly rely on customized DNA sequences for drug discovery, vaccine development, genetic engineering, and advanced genomic research. Gene synthesis enables researchers to create precise DNA constructs and accelerate therapeutic development timelines.
For detailed market insights, visit:
https://www.fortunebusinessinsights.com/gene-synthesis-market-117251
Solid-phase Synthesis Holds a Leading Position
Based on method, the market is segmented into Solid-phase Synthesis, Chip-based Synthesis, and PCR-based Enzyme Synthesis. Solid-phase synthesis accounted for approximately 46% of the global market, making it the leading method segment. Its widespread use in oligonucleotide production and custom DNA sequence generation is supporting segment growth.
Solid-phase synthesis offers high accuracy and scalability, making it suitable for pharmaceutical research, molecular diagnostics, and synthetic biology applications. Increasing demand for automated synthesis platforms and high-throughput research workflows is further supporting the adoption of this technology.
Custom Gene Synthesis Services Lead the Service Segment
Based on service, Custom Gene Synthesis Services accounted for approximately 48% of the global market. Pharmaceutical companies, biotechnology firms, and research organizations increasingly outsource DNA synthesis activities to specialized providers that offer sequence optimization, codon engineering, cloning, and vector integration services.
The growing need for customized DNA constructs in vaccine development, CRISPR research, cell therapy, and personalized medicine is supporting demand for these services. Increasing adoption of automated synthesis systems is also helping providers deliver customized sequences with improved turnaround times and scalability.
Therapeutics Development Leads the Application Segment
Based on application, Therapeutics Development accounted for approximately 39% of the global market. Synthetic genes play an important role in vaccine production, gene therapy, biologics development, and molecular engineering. The increasing adoption of mRNA technologies, cell therapies, immunotherapies, and precision medicine is supporting segment expansion.
Diagnostics accounted for approximately 23% of the market, supported by increasing utilization of synthetic DNA for molecular testing, genomic sequencing, infectious disease diagnostics, and assay development. Gene synthesis technologies are increasingly being incorporated into precision diagnostics and personalized healthcare workflows.
AI, Automation, and Synthetic Biology Shape the Market
An important trend in the Gene Synthesis Market is the increasing adoption of automation and AI-driven sequence optimization. Biotechnology companies are deploying automated synthesis platforms to reduce turnaround times, improve sequence accuracy, and increase production scalability. Artificial intelligence and machine learning are also being used to improve codon optimization and minimize synthesis errors.
Another major trend is the growing adoption of synthetic biology in pharmaceutical development, vaccine production, agricultural biotechnology, and industrial applications. Researchers are increasingly using synthetic genes for protein engineering, cell therapy development, advanced molecular diagnostics, and genetically engineered biological systems.
Expansion of Cell Therapy and Vaccine Development Creates New Opportunities
The expansion of cell therapy, immunotherapy, and vaccine development is creating significant opportunities for market participants. Pharmaceutical and biotechnology companies increasingly require customized DNA constructs for mRNA vaccines, CAR-T therapies, targeted genetic treatments, and other advanced therapeutic applications.
Opportunities are also emerging from the growing use of gene synthesis in agricultural biotechnology and industrial enzyme engineering. Researchers are developing genetically modified crops, microbial strains, and bio-based production systems using synthetic DNA technologies.
North America Leads the Regional Market
North America accounted for approximately 42% of the global Gene Synthesis Market, making it the leading regional market. The region benefits from advanced biotechnology infrastructure, strong pharmaceutical research activity, extensive genomics investments, and growing adoption of synthetic biology.
The U.S. remains a major contributor to the regional market, with the country accounting for approximately 40% of the North American market. Strong research funding, advanced biotechnology infrastructure, and increasing adoption of genomic technologies are supporting market growth.
Europe accounted for approximately 27% of the global market. Increasing genomic research activity, advanced healthcare systems, and strong pharmaceutical manufacturing capabilities are supporting regional expansion. Germany represented approximately 25% of the European market, while the U.K. accounted for approximately 19%.
Asia-Pacific accounted for approximately 24% of the global market. Expanding biotechnology investments, pharmaceutical manufacturing, genomics research, and precision medicine initiatives are supporting regional growth. China represented approximately 41% of the Asia-Pacific market, while Japan accounted for approximately 18%.
Japan's Gene Synthesis Market is supported by advanced biotechnology research, increasing investment in regenerative medicine, precision healthcare, and genomic technologies. Growing adoption of automated laboratory systems, molecular engineering, and cell therapy research is expected to create further opportunities for gene synthesis providers.
Competitive Landscape
The Gene Synthesis Market includes major companies focusing on DNA synthesis technologies, custom gene synthesis services, synthetic biology platforms, sequencing, and genomic research solutions. Major players include GenScript, Brooks Automation, Inc. (GENEWIZ), Boster Biological Technology, Twist Bioscience, ProteoGenix, Inc., Biomatik, ProMab Biotechnologies, Inc., Thermo Fisher Scientific, Inc., Integrated DNA Technologies, Inc., and OriGene Technologies, Inc.
Among the leading companies, Twist Bioscience accounted for approximately 17% of the market share, while Thermo Fisher Scientific, Inc. held approximately 15%, highlighting their strong positions within the competitive landscape.
Market Challenges
Despite strong growth prospects, the market faces challenges related to high synthesis costs and biosecurity concerns. Advanced DNA synthesis requires sophisticated laboratory infrastructure, automated equipment, and skilled scientific personnel, which can increase operating costs for manufacturers and research organizations.
The market also faces technical challenges related to long and complex DNA sequence synthesis. High GC-content regions, repetitive sequences, and large gene constructs can increase synthesis difficulty, error rates, production costs, and turnaround times. Continued investment in quality control, automation, and advanced synthesis technologies will be essential to overcome these challenges.
Request Sample Report
https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/gene-synthesis-market-117251
Future Outlook
The increasing adoption of AI-driven gene design, automated synthesis platforms, CRISPR technologies, cell therapy, mRNA applications, personalized medicine, and high-throughput genomic research will create significant opportunities for market participants. Continued investment in synthetic biology and advanced DNA manufacturing is expected to strengthen the long-term market outlook.
What’s Driving Japan’s Market? Discover the Latest Gene Synthesis Market Insights.
Top comments (0)